In a study of the physiological activities of AHA inhibitors, Lacroix-Desmazes et al. identified a subset of inhibitors in congenital hemophilia A that hydrolyze FVIII, resulting in FVIII inactivation [21, 22]. This evidence concerns the gene F8 and hemophilia A.